Stay updated on Pediatric Ph+ CML Clinical Trial.

Sign up to get notified when there's something new on the Pediatric Ph+ CML Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Ph+ CML Clinical Trial. page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pediatric nilotinib study is displayed, including its study design, outcomes, locations, and results information, in place of a 403 error page.
    Difference
    91%
    Check dated 2026-11-08T12:52:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T13:21:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the page’s 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:05:55.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:42.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:35:31.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the study record area, with a Home link, rather than study information.
    Difference
    0.5%
    Check dated 2026-10-04T15:48:50.000Z thumbnail image

Stay in the know with updates to Pediatric Ph+ CML Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pediatric Ph+ CML Clinical Trial. page.